erdafitinib,cetrelimab
janssen
['urothelial', 'norse', 'janssen']
for us #hcps attending #asco23, see dr. arlene siefker-radtke share final results from the phase 2 norse study of patients with metastatic #urothelialcarcinoma and fibroblast growth factor receptor alterations.
Dedicated to sharing Janssen Oncology scientific communications for US HCPs. Account run by Janssen Global Services LLC. Review our Guidelines: https://t.co/uieWByQjn3.